Abstract
Mild iron overload in chronic hepatitis C is associated with liver fibrosis, hepatitis C virus (HCV) genotype 1b infection, and an impaired response to interferon therapy. In this study we evaluated whether polymorphisms in the hemochromatosis gene HFE and the transferrin receptor gene TFR1 are associated with these typical findings. The study considered 246 HCV-infected patients and 200 blood donors as controls, in which C282Y, H63D, and S65C mutations (HFE) and the S142G polymorphism (TFR1) were detected. HCV genotype, serum ferritin levels, stainable intrahepatic iron, and grade of fibrosis according to the METAVIR score (F0–F4) were determined. In HCV-infected patients, heterozygosity for the C282Y mutation in HFE was significantly associated with elevated serum ferritin levels, stainable liver iron, and advanced fibrosis or cirrhosis (F2–F4). By multivariate logistic regression analysis the odds ratio for the development of advanced fibrosis or cirrhosis (F2–F4) was 2.5 for HCV-infected patients carrying a heterozygous C282Y mutation and 4.8 for HCV-infected patients with C282Y/H63D and C282Y/S65C compound heterozygosity. Heterozygosity for the C282Y mutation in HFE contributes to iron accumulation and fibrosis progression in chronic hepatitis C.
Similar content being viewed by others
Abbreviations
- HCV :
-
Hepatitis C virus
References
Di Bisceglie AM, Axiotis CA, Hoofnagle JH, Bacon BR (1992) Measurements of iron status in patients with chronic hepatitis. Gastroenterology 102:2108–2113
Farinati F, Cardin R, De Maria N, Della Libera G, Marafin C, Lecis E, Burra P, Floreani A, Cecchetto A, Naccarato R (1995) Iron storage, lipid peroxidation and gluthathione turnover in chronic anti-HCV positive patients. J Hepatol 22:449–456
Boucher E, Bourienne A, Adams P, Turlin B, Brissot P, Deugnier Y (1997) Liver iron concentration and distribution in chronic hepatitis C before and after interferon treatment. Gut 41:115–120
Barbaro G, Di Lorenzo G, Ribersani M, Soldini M, Giancaspro G, Bellomo G, Belloni G, Grisorio B, Barbarini G (1999) Serum ferritin and hepatic glutathione concentrations in chronic hepatitis C patients related to the hepatitis C virus genotype. J Hepatol 30:774–782
Beinker NK, Voigt MD, Arendse M, Smit J, Stander IA, Kirsch RE (1996) Threshold effect of liver iron content on hepatic inflammation and fibrosis in hepatitis B and C. J Hepatol 25:633–638
Hézode C, Cazeneuve C, Coué O, Roudot-Thoraval F, Lonjon I, Bastie A, Duvoux C, Pawlotsky JM, Zafrani ES, Amselem S, Dhumeaux D (1999) Liver iron accumulation in patients with chronic active hepatitis C: prevalence and role of hemochromatosis gene mutations and relationship with hepatic histological lesions. J Hepatol 31:979–984
Fargion S, Fracanzani AL, Sampietro M, Molteni V, Boldorini R, Mattioli M, Cesana B, Lunghi G, Piperno A, Valsecchi C, Fiorelli G (1997) Liver iron influences the response to interferon alpha therapy in chronic hepatitis C. Eur J Gastroenterol Hepatol 9:497–503
Olynyk JK, Reddy KR, Bisceglie AM, Jeffers LJ, Parker TI, Radick JL, Schiff ER, Bacon BR (1995) Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C. Gastroenterology 108:1104–1109
Van Thiel DH, Friedlander L, Fagiuoli S, Wright HI, Irish W, Gavaler JS (1994) Response to interferon α therapy is influenced by the iron content of the liver. J Hepatol 20:410–415
Fontana RJ, Israel J, LeClair P, Banner BF, Tortorelli K, Grace N, Levine RA, Fiarman G, Thiim M, Tavill AS, Bonkovsky HL (2000) Iron reduction before and during interferon therapy of chronic hepatitis C: results of a multicenter, randomized, controlled trial. Hepatology 31:730–736
Piperno A, D’Alba R, Fargion S, Roffi L, Sampietro M, Parma S, Arosio V, Faré M, Fiorelli G (1995) Liver iron concentration in chronic viral hepatitis: a study of 98 patients. Eur J Gastroenterol Hepatol 7:1203–1208
Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A et al (1996) A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 13:399–408
Pietrangelo A (2003) Haemochromatosis. Gut 52 [Suppl 2]:II23–II30
George DK, Goldwurm S, MacDonald GA, Cowley LL, Walker NI, Ward PJ, Jazwinska EC, Powell LW (1998) Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology 114:311–318
Roberts AG, Whatley SD, Morgan RR, Worwood M, Elder GH (1997) Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda. Lancet 349:321–323
Bulaj ZJ, Phillips JD, Ajioka RS, Franklin MR, Griffen LM, Guinee DJ, Edwards CQ, Kushner JP (2000) Hemochromatosis genes and other factors contributing to the pathogenesis of porphyria cutanea tarda. Blood 95:1565–1571
Smith BC, Grove J, Guzail MA, Day CP, Daly AK, Burt AD, Bassendine MF (1998) Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C. Hepatology 27:1695–1699
Bonkovsky HL, Troy N, McNeal K, Banner BF, Sharma A, Obando J, Mehta S, Koff RS, Liu Q, Hsieh CC (2002) Iron and HFE or TfR1 mutations as comorbid factors for development and progression of chronic hepatitis C. J Hepatol 37:848–854
Tung BY, Emond MJ, Bronner MP, Raaka SD, Cotler SJ, Kowdley KV (2003) Hepatitis C, iron status, and disease severity: relationship with HFE mutations. Gastroenterology 124:318–326
Erhardt A, Maschner-Olberg A, Mellenthin C, Kappert G, Adams O, Donner A, Willers R, Niederau C, Häussinger D (2003) HFE mutations and chronic hepatitis C: H63D and C282Y heterozygosity are independent risk factors for liver fibrosis and cirrhosis. J Hepatol 38:335–342
Kazemi-Shirazi L, Datz C, Maier-Dobersberger T, Kaserer K, Hackl F, Polli C, Steindl PE, Penner E, Ferenci P (1999) The relation of iron status and hemochromatosis gene mutations in patients with chronic hepatitis C. Gastroenterology 116:127–134
Martinelli ALC, Franco RF, Villanova MG, Figueiredo JFC, Secaf M, Tavella MH, Ramalho LNZ, Zucoloto S, Zago MA (1999) Are haemochromatosis mutations related to the severity of liver disease in hepatitis C virus infection? Acta Haematol 102:152–156
Negro F, Samii K, Rubbia-Brandt L, Quadri R, Male PJ, Zarski JP, Baud M, Giostra E, Beris P, Hadengue A (2000) Hemochromatosis gene mutations in chronic hepatitis C patients with and without liver siderosis. J Med Virol 60:21–27
Thorburn D, Curry G, Spooner R, Spence E, Oien K, Halls D, Fox R, McCruden EA, MacSween RN, Mills PR (2002) The role of iron and haemochromatosis gene mutations in the progression of liver disease in chronic hepatitis C. Gut 50:248–252
Feder JN, Penny DM, Irrinki A, Lee VK, Lebron JA, Watson N, Tsuchihashi Z, Sigal E, Bjorkman PJ, Schatzman RC (1998) The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc Natl Acad Sci USA 95:1472–1477
Riedel HD, Muckenthaler MU, Gehrke SG, Mohr I, Brennan K, Herrmann T, Fitscher BA, Hentze MW, Stremmel W (1999) HFE downregulates iron uptake from transferrin and induces iron-regulatory protein activity in stably transfected cells. Blood 94:3915–3921
Van Landeghem GF, Beckman LE, Wahlin A, Markevärn B, Beckman L (1998) Interaction between hemochromatosis and transferrin receptor genes in multiple myeloma. Lancet 352:1285–1286
Beckman LE, Van Landeghem GF, Sikström C, Wahlin A, Markevärn B, Hallmans G, Lenner P, Athlin L, Stenling R, Beckman L (1999) Interaction between haemochromatosis and transferrin receptor genes in different neoplastic disorders. Carcinogenesis 20:1231–1233
Beckman LE, Hägerstrand I, Stenling R, Van Landeghem GF, Beckman L (2000) Interaction between haemochromatosis and transferrn receptor genes in hepatocellular carcinoma. Oncology 59:317–322
Bedossa P, Poynard T (1996) An algorithm for the grading of activity in chronic hepatitis C. Hepatology 24:289–293
Von Ahsen N, Schutz E, Armstrong VW, Oellerich M (1999) Rapid detection of prothrombotic mutations of prothrombin (G20210A), factor V (G1691A), and methylenetetrahydrofolate reductase (C677T) by real-time fluorescence PCR with the LightCycler. Clin Chem 45:694–696
Bataller R, North KE, Brenner DA (2003) Genetic polymorphisms and the progression of liver fibrosis: a critical appraisal. Hepatology 37:493–503
Izumi N, Enomoto N, Uchihara M, Murakami T, Ono K, Noguchi O, Miyake S, Nouchi T, Fujisawa K, Marumo F, Sato C (1996) Hepatic iron contents and response to interferon-α in patients with chronic hepatitis C-relationship to genotypes of hepatitis C virus. Dig Dis Sci 41:989–994
Acknowledgements
This work was supported by the Deutsche Forschungsgemeinschaft (grant STR 216/10-1) and by the Forschungsförderungsprogramm of the College of Medicine, University of Heidelberg, Germany.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gehrke, S.G., Stremmel, W., Mathes, I. et al. Hemochromatosis and transferrin receptor gene polymorphisms in chronic hepatitis C: impact on iron status, liver injury and HCV genotype. J Mol Med 81, 780–787 (2003). https://doi.org/10.1007/s00109-003-0493-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00109-003-0493-0